Latest Ratings for REGN
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | Truist Securities | Maintains | Buy | |
| Feb 2022 | Oppenheimer | Maintains | Outperform | |
| Feb 2022 | Morgan Stanley | Maintains | Equal-Weight |
Beyond The Numbers: 18 Analysts Discuss Regeneron Pharmaceuticals Stock
